nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1B1—breast cancer	0.1	0.307	CbGaD
Lansoprazole—MAPT—Paclitaxel—breast cancer	0.0741	0.175	CbGbCtD
Lansoprazole—ABCG2—breast cancer	0.0689	0.211	CbGaD
Lansoprazole—CYP1A1—breast cancer	0.054	0.166	CbGaD
Lansoprazole—MAPT—Docetaxel—breast cancer	0.0536	0.126	CbGbCtD
Lansoprazole—CYP2D6—breast cancer	0.0402	0.123	CbGaD
Lansoprazole—CYP3A4—breast cancer	0.0345	0.106	CbGaD
Lansoprazole—ABCB1—breast cancer	0.0287	0.088	CbGaD
Lansoprazole—CYP1A1—Toremifene—breast cancer	0.0181	0.0427	CbGbCtD
Lansoprazole—CYP1B1—Tamoxifen—breast cancer	0.0151	0.0355	CbGbCtD
Lansoprazole—CYP1B1—Mitoxantrone—breast cancer	0.0147	0.0347	CbGbCtD
Lansoprazole—CYP1B1—Paclitaxel—breast cancer	0.0117	0.0277	CbGbCtD
Lansoprazole—CYP1A2—Anastrozole—breast cancer	0.00885	0.0209	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—breast cancer	0.00849	0.02	CbGbCtD
Lansoprazole—CYP1A2—Toremifene—breast cancer	0.00809	0.0191	CbGbCtD
Lansoprazole—CYP2C9—Anastrozole—breast cancer	0.00797	0.0188	CbGbCtD
Lansoprazole—CYP2C8—Lapatinib—breast cancer	0.00763	0.018	CbGbCtD
Lansoprazole—ABCG2—Tamoxifen—breast cancer	0.00717	0.0169	CbGbCtD
Lansoprazole—ABCB1—Toremifene—breast cancer	0.00708	0.0167	CbGbCtD
Lansoprazole—ABCG2—Mitoxantrone—breast cancer	0.00699	0.0165	CbGbCtD
Lansoprazole—CYP1A1—Tamoxifen—breast cancer	0.00662	0.0156	CbGbCtD
Lansoprazole—CYP2C19—Lapatinib—breast cancer	0.0064	0.0151	CbGbCtD
Lansoprazole—CYP1B1—Doxorubicin—breast cancer	0.00633	0.0149	CbGbCtD
Lansoprazole—CYP3A4—Exemestane—breast cancer	0.00612	0.0144	CbGbCtD
Lansoprazole—CYP2C9—Idarubicin—breast cancer	0.00604	0.0142	CbGbCtD
Lansoprazole—CYP2C8—Raloxifene—breast cancer	0.00578	0.0136	CbGbCtD
Lansoprazole—ABCG2—Paclitaxel—breast cancer	0.00558	0.0131	CbGbCtD
Lansoprazole—CYP2D6—Idarubicin—breast cancer	0.00553	0.013	CbGbCtD
Lansoprazole—ABCG2—Irinotecan—breast cancer	0.00551	0.013	CbGbCtD
Lansoprazole—ABCG2—Fluorouracil—breast cancer	0.00528	0.0124	CbGbCtD
Lansoprazole—ABCG2—Carboplatin—breast cancer	0.00525	0.0124	CbGbCtD
Lansoprazole—CYP3A4—Letrozole—breast cancer	0.0052	0.0123	CbGbCtD
Lansoprazole—ABCB1—Lapatinib—breast cancer	0.00516	0.0122	CbGbCtD
Lansoprazole—CYP3A4—Anastrozole—breast cancer	0.00464	0.0109	CbGbCtD
Lansoprazole—CYP3A4—Toremifene—breast cancer	0.00424	0.00999	CbGbCtD
Lansoprazole—ABCG2—Docetaxel—breast cancer	0.00404	0.00951	CbGbCtD
Lansoprazole—CYP3A4—Fulvestrant—breast cancer	0.00394	0.00929	CbGbCtD
Lansoprazole—CYP2C8—Tamoxifen—breast cancer	0.00382	0.009	CbGbCtD
Lansoprazole—CYP3A4—Thiotepa—breast cancer	0.00351	0.00828	CbGbCtD
Lansoprazole—CYP2C9—Capecitabine—breast cancer	0.00331	0.0078	CbGbCtD
Lansoprazole—CYP3A4—Ixabepilone—breast cancer	0.00321	0.00757	CbGbCtD
Lansoprazole—CYP2C19—Tamoxifen—breast cancer	0.0032	0.00755	CbGbCtD
Lansoprazole—CYP3A4—Lapatinib—breast cancer	0.00309	0.00729	CbGbCtD
Lansoprazole—ABCG2—Doxorubicin—breast cancer	0.00301	0.00709	CbGbCtD
Lansoprazole—CYP2C8—Paclitaxel—breast cancer	0.00297	0.007	CbGbCtD
Lansoprazole—CYP1A2—Tamoxifen—breast cancer	0.00296	0.00697	CbGbCtD
Lansoprazole—ABCG2—Methotrexate—breast cancer	0.00291	0.00687	CbGbCtD
Lansoprazole—ABCB1—Vinorelbine—breast cancer	0.00286	0.00675	CbGbCtD
Lansoprazole—CYP2C8—Fluorouracil—breast cancer	0.00281	0.00663	CbGbCtD
Lansoprazole—CYP2D6—Vinorelbine—breast cancer	0.0027	0.00636	CbGbCtD
Lansoprazole—CYP2C9—Tamoxifen—breast cancer	0.00266	0.00628	CbGbCtD
Lansoprazole—ABCB1—Tamoxifen—breast cancer	0.00259	0.00609	CbGbCtD
Lansoprazole—ABCB1—Mitoxantrone—breast cancer	0.00252	0.00594	CbGbCtD
Lansoprazole—CYP2D6—Tamoxifen—breast cancer	0.00244	0.00574	CbGbCtD
Lansoprazole—CYP3A4—Raloxifene—breast cancer	0.00234	0.00552	CbGbCtD
Lansoprazole—ABCB1—Gemcitabine—breast cancer	0.00223	0.00525	CbGbCtD
Lansoprazole—CYP1A2—Fluorouracil—breast cancer	0.00218	0.00513	CbGbCtD
Lansoprazole—CYP2C9—Paclitaxel—breast cancer	0.00207	0.00489	CbGbCtD
Lansoprazole—ABCB1—Paclitaxel—breast cancer	0.00201	0.00474	CbGbCtD
Lansoprazole—ABCB1—Irinotecan—breast cancer	0.00199	0.00468	CbGbCtD
Lansoprazole—CYP2C9—Fluorouracil—breast cancer	0.00196	0.00463	CbGbCtD
Lansoprazole—ABCB1—Vinblastine—breast cancer	0.00177	0.00416	CbGbCtD
Lansoprazole—CYP3A4—Vinorelbine—breast cancer	0.00172	0.00404	CbGbCtD
Lansoprazole—CYP2D6—Vinblastine—breast cancer	0.00166	0.00392	CbGbCtD
Lansoprazole—CYP3A4—Tamoxifen—breast cancer	0.00155	0.00365	CbGbCtD
Lansoprazole—CYP3A4—Mitoxantrone—breast cancer	0.00151	0.00356	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—breast cancer	0.00145	0.00343	CbGbCtD
Lansoprazole—CYP3A4—Paclitaxel—breast cancer	0.00121	0.00284	CbGbCtD
Lansoprazole—CYP3A4—Irinotecan—breast cancer	0.00119	0.0028	CbGbCtD
Lansoprazole—ATP4B—endocrine gland—breast cancer	0.00113	0.0655	CbGeAlD
Lansoprazole—ABCB1—Doxorubicin—breast cancer	0.00108	0.00256	CbGbCtD
Lansoprazole—CYP3A4—Vinblastine—breast cancer	0.00106	0.00249	CbGbCtD
Lansoprazole—ABCB1—Methotrexate—breast cancer	0.00105	0.00248	CbGbCtD
Lansoprazole—CYP2D6—Doxorubicin—breast cancer	0.00102	0.00241	CbGbCtD
Lansoprazole—CYP3A4—Docetaxel—breast cancer	0.000872	0.00205	CbGbCtD
Lansoprazole—MAPT—pituitary gland—breast cancer	0.000859	0.0496	CbGeAlD
Lansoprazole—MAPT—adipose tissue—breast cancer	0.000855	0.0494	CbGeAlD
Lansoprazole—ATP4A—epithelium—breast cancer	0.000786	0.0454	CbGeAlD
Lansoprazole—MAPT—adrenal gland—breast cancer	0.000767	0.0443	CbGeAlD
Lansoprazole—CYP3A4—Doxorubicin—breast cancer	0.00065	0.00153	CbGbCtD
Lansoprazole—CYP4A11—endocrine gland—breast cancer	0.000613	0.0354	CbGeAlD
Lansoprazole—ATP4A—female reproductive system—breast cancer	0.000584	0.0337	CbGeAlD
Lansoprazole—ATP4A—adrenal gland—breast cancer	0.00057	0.0329	CbGeAlD
Lansoprazole—CYP1B1—mammary gland—breast cancer	0.000562	0.0324	CbGeAlD
Lansoprazole—Thiabendazole—CYP1A1—breast cancer	0.00054	0.176	CrCbGaD
Lansoprazole—Pantoprazole—SLCO1B1—breast cancer	0.000499	0.163	CrCbGaD
Lansoprazole—ATP4A—endocrine gland—breast cancer	0.000494	0.0285	CbGeAlD
Lansoprazole—MAPT—lymph node—breast cancer	0.00046	0.0265	CbGeAlD
Lansoprazole—CYP2C8—mammary gland—breast cancer	0.00043	0.0248	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—breast cancer	0.000406	0.0234	CbGeAlD
Lansoprazole—CYP2C9—mammary gland—breast cancer	0.000382	0.0221	CbGeAlD
Lansoprazole—CYP1A2—nipple—breast cancer	0.000333	0.0192	CbGeAlD
Lansoprazole—CYP1A1—nipple—breast cancer	0.000328	0.019	CbGeAlD
Lansoprazole—CYP1B1—skin of body—breast cancer	0.000298	0.0172	CbGeAlD
Lansoprazole—CYP1B1—uterus—breast cancer	0.000259	0.0149	CbGeAlD
Lansoprazole—Omeprazole—CYP1B1—breast cancer	0.000257	0.0838	CrCbGaD
Lansoprazole—CYP1B1—pituitary gland—breast cancer	0.000254	0.0147	CbGeAlD
Lansoprazole—CYP1B1—adipose tissue—breast cancer	0.000253	0.0146	CbGeAlD
Lansoprazole—CYP1B1—female reproductive system—breast cancer	0.000232	0.0134	CbGeAlD
Lansoprazole—CYP1B1—adrenal gland—breast cancer	0.000227	0.0131	CbGeAlD
Lansoprazole—CYP1A1—epithelium—breast cancer	0.000221	0.0128	CbGeAlD
Lansoprazole—Rabeprazole—ABCG2—breast cancer	0.000217	0.0709	CrCbGaD
Lansoprazole—Pantoprazole—ABCG2—breast cancer	0.000217	0.0709	CrCbGaD
Lansoprazole—CYP2C8—endometrium—breast cancer	0.000215	0.0124	CbGeAlD
Lansoprazole—CYP1B1—female gonad—breast cancer	0.000211	0.0122	CbGeAlD
Lansoprazole—CYP1A1—skin of body—breast cancer	0.00021	0.0121	CbGeAlD
Lansoprazole—ABCG2—endometrium—breast cancer	0.000209	0.0121	CbGeAlD
Lansoprazole—CYP1B1—endocrine gland—breast cancer	0.000197	0.0114	CbGeAlD
Lansoprazole—CYP2C8—pituitary gland—breast cancer	0.000194	0.0112	CbGeAlD
Lansoprazole—ABCG2—uterus—breast cancer	0.000193	0.0111	CbGeAlD
Lansoprazole—ABCG2—pituitary gland—breast cancer	0.000189	0.0109	CbGeAlD
Lansoprazole—ABCG2—adipose tissue—breast cancer	0.000188	0.0109	CbGeAlD
Lansoprazole—CYP1A1—uterus—breast cancer	0.000183	0.0105	CbGeAlD
Lansoprazole—CYP1A1—adipose tissue—breast cancer	0.000179	0.0103	CbGeAlD
Lansoprazole—CYP2C8—female reproductive system—breast cancer	0.000178	0.0103	CbGeAlD
Lansoprazole—Omeprazole—ABCG2—breast cancer	0.000177	0.0578	CrCbGaD
Lansoprazole—CYP2C19—endocrine gland—breast cancer	0.000173	0.00996	CbGeAlD
Lansoprazole—Rabeprazole—CYP1A1—breast cancer	0.00017	0.0555	CrCbGaD
Lansoprazole—ABCG2—adrenal gland—breast cancer	0.000169	0.00975	CbGeAlD
Lansoprazole—CYP1A1—female reproductive system—breast cancer	0.000164	0.00948	CbGeAlD
Lansoprazole—ABCG2—bone marrow—breast cancer	0.000163	0.00943	CbGeAlD
Lansoprazole—CYP2C9—female reproductive system—breast cancer	0.000158	0.00913	CbGeAlD
Lansoprazole—ABCG2—female gonad—breast cancer	0.000157	0.00909	CbGeAlD
Lansoprazole—CYP2C8—endocrine gland—breast cancer	0.000151	0.00869	CbGeAlD
Lansoprazole—Esomeprazole—CYP3A4—breast cancer	0.00015	0.049	CrCbGaD
Lansoprazole—CYP1A1—female gonad—breast cancer	0.000149	0.00863	CbGeAlD
Lansoprazole—CYP1A2—endocrine gland—breast cancer	0.000141	0.00814	CbGeAlD
Lansoprazole—ABCB1—embryo—breast cancer	0.000141	0.00813	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—breast cancer	0.000139	0.00803	CbGeAlD
Lansoprazole—Omeprazole—CYP1A1—breast cancer	0.000139	0.0452	CrCbGaD
Lansoprazole—CYP1B1—lymph node—breast cancer	0.000136	0.00785	CbGeAlD
Lansoprazole—CYP2C9—endocrine gland—breast cancer	0.000134	0.00772	CbGeAlD
Lansoprazole—Rabeprazole—CYP2D6—breast cancer	0.000127	0.0413	CrCbGaD
Lansoprazole—CYP3A4—female reproductive system—breast cancer	0.000121	0.00696	CbGeAlD
Lansoprazole—CYP2D6—female reproductive system—breast cancer	0.000119	0.00685	CbGeAlD
Lansoprazole—ABCB1—epithelium—breast cancer	0.000115	0.00663	CbGeAlD
Lansoprazole—Rabeprazole—CYP3A4—breast cancer	0.000109	0.0354	CrCbGaD
Lansoprazole—Pantoprazole—CYP3A4—breast cancer	0.000109	0.0354	CrCbGaD
Lansoprazole—CYP2D6—female gonad—breast cancer	0.000108	0.00623	CbGeAlD
Lansoprazole—Omeprazole—CYP2D6—breast cancer	0.000103	0.0337	CrCbGaD
Lansoprazole—ABCB1—endometrium—breast cancer	0.000103	0.00595	CbGeAlD
Lansoprazole—CYP3A4—endocrine gland—breast cancer	0.000102	0.00589	CbGeAlD
Lansoprazole—ABCG2—lymph node—breast cancer	0.000101	0.00584	CbGeAlD
Lansoprazole—CYP2D6—endocrine gland—breast cancer	0.0001	0.00579	CbGeAlD
Lansoprazole—CYP1A1—lymph node—breast cancer	9.61e-05	0.00555	CbGeAlD
Lansoprazole—ABCB1—uterus—breast cancer	9.49e-05	0.00548	CbGeAlD
Lansoprazole—ABCB1—pituitary gland—breast cancer	9.32e-05	0.00538	CbGeAlD
Lansoprazole—ABCB1—adipose tissue—breast cancer	9.28e-05	0.00536	CbGeAlD
Lansoprazole—Pantoprazole—ABCB1—breast cancer	9.04e-05	0.0295	CrCbGaD
Lansoprazole—Omeprazole—CYP3A4—breast cancer	8.85e-05	0.0289	CrCbGaD
Lansoprazole—ABCB1—female reproductive system—breast cancer	8.53e-05	0.00493	CbGeAlD
Lansoprazole—ABCB1—adrenal gland—breast cancer	8.33e-05	0.00481	CbGeAlD
Lansoprazole—ABCB1—bone marrow—breast cancer	8.06e-05	0.00465	CbGeAlD
Lansoprazole—ABCB1—female gonad—breast cancer	7.76e-05	0.00448	CbGeAlD
Lansoprazole—Omeprazole—ABCB1—breast cancer	7.37e-05	0.024	CrCbGaD
Lansoprazole—ABCB1—endocrine gland—breast cancer	7.22e-05	0.00417	CbGeAlD
Lansoprazole—ABCB1—lymph node—breast cancer	4.99e-05	0.00288	CbGeAlD
Lansoprazole—Angiopathy—Epirubicin—breast cancer	1.32e-05	9.27e-05	CcSEcCtD
Lansoprazole—Urethral disorder—Doxorubicin—breast cancer	1.32e-05	9.27e-05	CcSEcCtD
Lansoprazole—Nausea—Mitoxantrone—breast cancer	1.32e-05	9.25e-05	CcSEcCtD
Lansoprazole—Nausea—Irinotecan—breast cancer	1.32e-05	9.25e-05	CcSEcCtD
Lansoprazole—Immune system disorder—Epirubicin—breast cancer	1.31e-05	9.23e-05	CcSEcCtD
Lansoprazole—Mediastinal disorder—Epirubicin—breast cancer	1.31e-05	9.21e-05	CcSEcCtD
Lansoprazole—Pain—Docetaxel—breast cancer	1.31e-05	9.21e-05	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—breast cancer	1.31e-05	9.21e-05	CcSEcCtD
Lansoprazole—Back pain—Methotrexate—breast cancer	1.31e-05	9.2e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Capecitabine—breast cancer	1.3e-05	9.18e-05	CcSEcCtD
Lansoprazole—Chills—Epirubicin—breast cancer	1.3e-05	9.17e-05	CcSEcCtD
Lansoprazole—Arrhythmia—Epirubicin—breast cancer	1.3e-05	9.13e-05	CcSEcCtD
Lansoprazole—Visual impairment—Doxorubicin—breast cancer	1.3e-05	9.11e-05	CcSEcCtD
Lansoprazole—Asthenia—Paclitaxel—breast cancer	1.3e-05	9.11e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Capecitabine—breast cancer	1.29e-05	9.06e-05	CcSEcCtD
Lansoprazole—Alopecia—Epirubicin—breast cancer	1.28e-05	9.03e-05	CcSEcCtD
Lansoprazole—Nausea—Gemcitabine—breast cancer	1.28e-05	9.01e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Capecitabine—breast cancer	1.28e-05	9e-05	CcSEcCtD
Lansoprazole—Fatigue—Capecitabine—breast cancer	1.28e-05	8.99e-05	CcSEcCtD
Lansoprazole—Pruritus—Paclitaxel—breast cancer	1.28e-05	8.99e-05	CcSEcCtD
Lansoprazole—Vision blurred—Methotrexate—breast cancer	1.27e-05	8.96e-05	CcSEcCtD
Lansoprazole—Mental disorder—Epirubicin—breast cancer	1.27e-05	8.95e-05	CcSEcCtD
Lansoprazole—Erythema multiforme—Doxorubicin—breast cancer	1.27e-05	8.94e-05	CcSEcCtD
Lansoprazole—Constipation—Capecitabine—breast cancer	1.27e-05	8.91e-05	CcSEcCtD
Lansoprazole—Pain—Capecitabine—breast cancer	1.27e-05	8.91e-05	CcSEcCtD
Lansoprazole—Malnutrition—Epirubicin—breast cancer	1.27e-05	8.9e-05	CcSEcCtD
Lansoprazole—Erythema—Epirubicin—breast cancer	1.27e-05	8.9e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—breast cancer	1.26e-05	8.87e-05	CcSEcCtD
Lansoprazole—Nausea—Fluorouracil—breast cancer	1.26e-05	8.86e-05	CcSEcCtD
Lansoprazole—Eye disorder—Doxorubicin—breast cancer	1.26e-05	8.84e-05	CcSEcCtD
Lansoprazole—Ill-defined disorder—Methotrexate—breast cancer	1.25e-05	8.82e-05	CcSEcCtD
Lansoprazole—Tinnitus—Doxorubicin—breast cancer	1.25e-05	8.82e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—breast cancer	1.25e-05	8.8e-05	CcSEcCtD
Lansoprazole—Anaemia—Methotrexate—breast cancer	1.25e-05	8.79e-05	CcSEcCtD
Lansoprazole—Cardiac disorder—Doxorubicin—breast cancer	1.25e-05	8.78e-05	CcSEcCtD
Lansoprazole—Flatulence—Epirubicin—breast cancer	1.25e-05	8.77e-05	CcSEcCtD
Lansoprazole—Tension—Epirubicin—breast cancer	1.24e-05	8.73e-05	CcSEcCtD
Lansoprazole—Dysgeusia—Epirubicin—breast cancer	1.24e-05	8.71e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Paclitaxel—breast cancer	1.24e-05	8.69e-05	CcSEcCtD
Lansoprazole—Nervousness—Epirubicin—breast cancer	1.23e-05	8.64e-05	CcSEcCtD
Lansoprazole—Back pain—Epirubicin—breast cancer	1.22e-05	8.61e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Capecitabine—breast cancer	1.22e-05	8.59e-05	CcSEcCtD
Lansoprazole—Angiopathy—Doxorubicin—breast cancer	1.22e-05	8.58e-05	CcSEcCtD
Lansoprazole—Malaise—Methotrexate—breast cancer	1.22e-05	8.57e-05	CcSEcCtD
Lansoprazole—Muscle spasms—Epirubicin—breast cancer	1.22e-05	8.55e-05	CcSEcCtD
Lansoprazole—Immune system disorder—Doxorubicin—breast cancer	1.21e-05	8.54e-05	CcSEcCtD
Lansoprazole—Vertigo—Methotrexate—breast cancer	1.21e-05	8.54e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Capecitabine—breast cancer	1.21e-05	8.52e-05	CcSEcCtD
Lansoprazole—Mediastinal disorder—Doxorubicin—breast cancer	1.21e-05	8.52e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—breast cancer	1.21e-05	8.51e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—breast cancer	1.21e-05	8.51e-05	CcSEcCtD
Lansoprazole—Leukopenia—Methotrexate—breast cancer	1.21e-05	8.51e-05	CcSEcCtD
Lansoprazole—Chills—Doxorubicin—breast cancer	1.21e-05	8.49e-05	CcSEcCtD
Lansoprazole—Arrhythmia—Doxorubicin—breast cancer	1.2e-05	8.45e-05	CcSEcCtD
Lansoprazole—Dizziness—Paclitaxel—breast cancer	1.19e-05	8.4e-05	CcSEcCtD
Lansoprazole—Vision blurred—Epirubicin—breast cancer	1.19e-05	8.39e-05	CcSEcCtD
Lansoprazole—Alopecia—Doxorubicin—breast cancer	1.19e-05	8.36e-05	CcSEcCtD
Lansoprazole—Cough—Methotrexate—breast cancer	1.18e-05	8.3e-05	CcSEcCtD
Lansoprazole—Mental disorder—Doxorubicin—breast cancer	1.18e-05	8.29e-05	CcSEcCtD
Lansoprazole—Urticaria—Capecitabine—breast cancer	1.18e-05	8.28e-05	CcSEcCtD
Lansoprazole—Ill-defined disorder—Epirubicin—breast cancer	1.17e-05	8.26e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Capecitabine—breast cancer	1.17e-05	8.24e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Capecitabine—breast cancer	1.17e-05	8.24e-05	CcSEcCtD
Lansoprazole—Convulsion—Methotrexate—breast cancer	1.17e-05	8.24e-05	CcSEcCtD
Lansoprazole—Malnutrition—Doxorubicin—breast cancer	1.17e-05	8.23e-05	CcSEcCtD
Lansoprazole—Erythema—Doxorubicin—breast cancer	1.17e-05	8.23e-05	CcSEcCtD
Lansoprazole—Anaemia—Epirubicin—breast cancer	1.17e-05	8.22e-05	CcSEcCtD
Lansoprazole—Agitation—Epirubicin—breast cancer	1.16e-05	8.18e-05	CcSEcCtD
Lansoprazole—Flatulence—Doxorubicin—breast cancer	1.15e-05	8.11e-05	CcSEcCtD
Lansoprazole—Arthralgia—Methotrexate—breast cancer	1.15e-05	8.09e-05	CcSEcCtD
Lansoprazole—Myalgia—Methotrexate—breast cancer	1.15e-05	8.09e-05	CcSEcCtD
Lansoprazole—Chest pain—Methotrexate—breast cancer	1.15e-05	8.09e-05	CcSEcCtD
Lansoprazole—Tension—Doxorubicin—breast cancer	1.15e-05	8.08e-05	CcSEcCtD
Lansoprazole—Vomiting—Paclitaxel—breast cancer	1.15e-05	8.08e-05	CcSEcCtD
Lansoprazole—Dysgeusia—Doxorubicin—breast cancer	1.15e-05	8.06e-05	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.14e-05	8.04e-05	CcSEcCtD
Lansoprazole—Malaise—Epirubicin—breast cancer	1.14e-05	8.02e-05	CcSEcCtD
Lansoprazole—Rash—Paclitaxel—breast cancer	1.14e-05	8.01e-05	CcSEcCtD
Lansoprazole—Dermatitis—Paclitaxel—breast cancer	1.14e-05	8e-05	CcSEcCtD
Lansoprazole—Discomfort—Methotrexate—breast cancer	1.14e-05	8e-05	CcSEcCtD
Lansoprazole—Nervousness—Doxorubicin—breast cancer	1.14e-05	8e-05	CcSEcCtD
Lansoprazole—Vertigo—Epirubicin—breast cancer	1.14e-05	7.99e-05	CcSEcCtD
Lansoprazole—Syncope—Epirubicin—breast cancer	1.13e-05	7.98e-05	CcSEcCtD
Lansoprazole—Leukopenia—Epirubicin—breast cancer	1.13e-05	7.96e-05	CcSEcCtD
Lansoprazole—Back pain—Doxorubicin—breast cancer	1.13e-05	7.96e-05	CcSEcCtD
Lansoprazole—Headache—Paclitaxel—breast cancer	1.13e-05	7.96e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Docetaxel—breast cancer	1.13e-05	7.93e-05	CcSEcCtD
Lansoprazole—Muscle spasms—Doxorubicin—breast cancer	1.13e-05	7.92e-05	CcSEcCtD
Lansoprazole—Palpitations—Epirubicin—breast cancer	1.12e-05	7.86e-05	CcSEcCtD
Lansoprazole—Confusional state—Methotrexate—breast cancer	1.11e-05	7.82e-05	CcSEcCtD
Lansoprazole—Loss of consciousness—Epirubicin—breast cancer	1.11e-05	7.82e-05	CcSEcCtD
Lansoprazole—Cough—Epirubicin—breast cancer	1.1e-05	7.76e-05	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methotrexate—breast cancer	1.1e-05	7.76e-05	CcSEcCtD
Lansoprazole—Vision blurred—Doxorubicin—breast cancer	1.1e-05	7.76e-05	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—breast cancer	1.1e-05	7.72e-05	CcSEcCtD
Lansoprazole—Convulsion—Epirubicin—breast cancer	1.1e-05	7.71e-05	CcSEcCtD
Lansoprazole—Infection—Methotrexate—breast cancer	1.1e-05	7.71e-05	CcSEcCtD
Lansoprazole—Hypertension—Epirubicin—breast cancer	1.09e-05	7.68e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Capecitabine—breast cancer	1.09e-05	7.68e-05	CcSEcCtD
Lansoprazole—Ill-defined disorder—Doxorubicin—breast cancer	1.09e-05	7.64e-05	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—breast cancer	1.08e-05	7.62e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Methotrexate—breast cancer	1.08e-05	7.61e-05	CcSEcCtD
Lansoprazole—Anaemia—Doxorubicin—breast cancer	1.08e-05	7.61e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Methotrexate—breast cancer	1.08e-05	7.6e-05	CcSEcCtD
Lansoprazole—Arthralgia—Epirubicin—breast cancer	1.08e-05	7.58e-05	CcSEcCtD
Lansoprazole—Chest pain—Epirubicin—breast cancer	1.08e-05	7.58e-05	CcSEcCtD
Lansoprazole—Myalgia—Epirubicin—breast cancer	1.08e-05	7.58e-05	CcSEcCtD
Lansoprazole—Agitation—Doxorubicin—breast cancer	1.08e-05	7.57e-05	CcSEcCtD
Lansoprazole—Anxiety—Epirubicin—breast cancer	1.07e-05	7.55e-05	CcSEcCtD
Lansoprazole—Nausea—Paclitaxel—breast cancer	1.07e-05	7.54e-05	CcSEcCtD
Lansoprazole—Skin disorder—Methotrexate—breast cancer	1.07e-05	7.54e-05	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.07e-05	7.52e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methotrexate—breast cancer	1.07e-05	7.5e-05	CcSEcCtD
Lansoprazole—Discomfort—Epirubicin—breast cancer	1.06e-05	7.48e-05	CcSEcCtD
Lansoprazole—Asthenia—Capecitabine—breast cancer	1.06e-05	7.48e-05	CcSEcCtD
Lansoprazole—Malaise—Doxorubicin—breast cancer	1.06e-05	7.42e-05	CcSEcCtD
Lansoprazole—Dry mouth—Epirubicin—breast cancer	1.05e-05	7.41e-05	CcSEcCtD
Lansoprazole—Vertigo—Doxorubicin—breast cancer	1.05e-05	7.4e-05	CcSEcCtD
Lansoprazole—Anorexia—Methotrexate—breast cancer	1.05e-05	7.4e-05	CcSEcCtD
Lansoprazole—Syncope—Doxorubicin—breast cancer	1.05e-05	7.38e-05	CcSEcCtD
Lansoprazole—Pruritus—Capecitabine—breast cancer	1.05e-05	7.37e-05	CcSEcCtD
Lansoprazole—Leukopenia—Doxorubicin—breast cancer	1.05e-05	7.37e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—breast cancer	1.05e-05	7.37e-05	CcSEcCtD
Lansoprazole—Confusional state—Epirubicin—breast cancer	1.04e-05	7.32e-05	CcSEcCtD
Lansoprazole—Palpitations—Doxorubicin—breast cancer	1.03e-05	7.28e-05	CcSEcCtD
Lansoprazole—Anaphylactic shock—Epirubicin—breast cancer	1.03e-05	7.26e-05	CcSEcCtD
Lansoprazole—Oedema—Epirubicin—breast cancer	1.03e-05	7.26e-05	CcSEcCtD
Lansoprazole—Hypotension—Methotrexate—breast cancer	1.03e-05	7.25e-05	CcSEcCtD
Lansoprazole—Loss of consciousness—Doxorubicin—breast cancer	1.03e-05	7.24e-05	CcSEcCtD
Lansoprazole—Infection—Epirubicin—breast cancer	1.03e-05	7.21e-05	CcSEcCtD
Lansoprazole—Cough—Doxorubicin—breast cancer	1.02e-05	7.18e-05	CcSEcCtD
Lansoprazole—Shock—Epirubicin—breast cancer	1.02e-05	7.14e-05	CcSEcCtD
Lansoprazole—Convulsion—Doxorubicin—breast cancer	1.01e-05	7.13e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Capecitabine—breast cancer	1.01e-05	7.13e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Epirubicin—breast cancer	1.01e-05	7.12e-05	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—breast cancer	1.01e-05	7.12e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Epirubicin—breast cancer	1.01e-05	7.11e-05	CcSEcCtD
Lansoprazole—Hypertension—Doxorubicin—breast cancer	1.01e-05	7.11e-05	CcSEcCtD
Lansoprazole—Tachycardia—Epirubicin—breast cancer	1.01e-05	7.09e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.01e-05	7.07e-05	CcSEcCtD
Lansoprazole—Skin disorder—Epirubicin—breast cancer	1e-05	7.05e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Epirubicin—breast cancer	9.98e-06	7.02e-05	CcSEcCtD
Lansoprazole—Insomnia—Methotrexate—breast cancer	9.98e-06	7.02e-05	CcSEcCtD
Lansoprazole—Arthralgia—Doxorubicin—breast cancer	9.97e-06	7.01e-05	CcSEcCtD
Lansoprazole—Myalgia—Doxorubicin—breast cancer	9.97e-06	7.01e-05	CcSEcCtD
Lansoprazole—Chest pain—Doxorubicin—breast cancer	9.97e-06	7.01e-05	CcSEcCtD
Lansoprazole—Anxiety—Doxorubicin—breast cancer	9.93e-06	6.98e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Methotrexate—breast cancer	9.91e-06	6.97e-05	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.9e-06	6.96e-05	CcSEcCtD
Lansoprazole—Discomfort—Doxorubicin—breast cancer	9.85e-06	6.93e-05	CcSEcCtD
Lansoprazole—Anorexia—Epirubicin—breast cancer	9.84e-06	6.92e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Methotrexate—breast cancer	9.84e-06	6.92e-05	CcSEcCtD
Lansoprazole—Somnolence—Methotrexate—breast cancer	9.81e-06	6.9e-05	CcSEcCtD
Lansoprazole—Dizziness—Capecitabine—breast cancer	9.8e-06	6.89e-05	CcSEcCtD
Lansoprazole—Dry mouth—Doxorubicin—breast cancer	9.75e-06	6.85e-05	CcSEcCtD
Lansoprazole—Vomiting—Docetaxel—breast cancer	9.74e-06	6.85e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Methotrexate—breast cancer	9.71e-06	6.83e-05	CcSEcCtD
Lansoprazole—Rash—Docetaxel—breast cancer	9.65e-06	6.79e-05	CcSEcCtD
Lansoprazole—Hypotension—Epirubicin—breast cancer	9.65e-06	6.79e-05	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—breast cancer	9.65e-06	6.78e-05	CcSEcCtD
Lansoprazole—Confusional state—Doxorubicin—breast cancer	9.64e-06	6.77e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Methotrexate—breast cancer	9.59e-06	6.75e-05	CcSEcCtD
Lansoprazole—Headache—Docetaxel—breast cancer	9.59e-06	6.74e-05	CcSEcCtD
Lansoprazole—Oedema—Doxorubicin—breast cancer	9.56e-06	6.72e-05	CcSEcCtD
Lansoprazole—Anaphylactic shock—Doxorubicin—breast cancer	9.56e-06	6.72e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Methotrexate—breast cancer	9.53e-06	6.7e-05	CcSEcCtD
Lansoprazole—Fatigue—Methotrexate—breast cancer	9.51e-06	6.69e-05	CcSEcCtD
Lansoprazole—Infection—Doxorubicin—breast cancer	9.49e-06	6.68e-05	CcSEcCtD
Lansoprazole—Pain—Methotrexate—breast cancer	9.44e-06	6.64e-05	CcSEcCtD
Lansoprazole—Vomiting—Capecitabine—breast cancer	9.43e-06	6.63e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Epirubicin—breast cancer	9.41e-06	6.62e-05	CcSEcCtD
Lansoprazole—Shock—Doxorubicin—breast cancer	9.4e-06	6.61e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Doxorubicin—breast cancer	9.37e-06	6.59e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Doxorubicin—breast cancer	9.36e-06	6.58e-05	CcSEcCtD
Lansoprazole—Rash—Capecitabine—breast cancer	9.35e-06	6.57e-05	CcSEcCtD
Lansoprazole—Insomnia—Epirubicin—breast cancer	9.34e-06	6.57e-05	CcSEcCtD
Lansoprazole—Dermatitis—Capecitabine—breast cancer	9.34e-06	6.57e-05	CcSEcCtD
Lansoprazole—Tachycardia—Doxorubicin—breast cancer	9.33e-06	6.56e-05	CcSEcCtD
Lansoprazole—Headache—Capecitabine—breast cancer	9.29e-06	6.53e-05	CcSEcCtD
Lansoprazole—Skin disorder—Doxorubicin—breast cancer	9.28e-06	6.53e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Epirubicin—breast cancer	9.27e-06	6.52e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Doxorubicin—breast cancer	9.24e-06	6.5e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Epirubicin—breast cancer	9.21e-06	6.47e-05	CcSEcCtD
Lansoprazole—Somnolence—Epirubicin—breast cancer	9.18e-06	6.46e-05	CcSEcCtD
Lansoprazole—Anorexia—Doxorubicin—breast cancer	9.11e-06	6.4e-05	CcSEcCtD
Lansoprazole—Nausea—Docetaxel—breast cancer	9.09e-06	6.39e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Methotrexate—breast cancer	9.09e-06	6.39e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Epirubicin—breast cancer	9.09e-06	6.39e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methotrexate—breast cancer	9.02e-06	6.35e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Epirubicin—breast cancer	8.98e-06	6.31e-05	CcSEcCtD
Lansoprazole—Hypotension—Doxorubicin—breast cancer	8.93e-06	6.28e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Epirubicin—breast cancer	8.92e-06	6.27e-05	CcSEcCtD
Lansoprazole—Fatigue—Epirubicin—breast cancer	8.9e-06	6.26e-05	CcSEcCtD
Lansoprazole—Pain—Epirubicin—breast cancer	8.83e-06	6.21e-05	CcSEcCtD
Lansoprazole—Constipation—Epirubicin—breast cancer	8.83e-06	6.21e-05	CcSEcCtD
Lansoprazole—Nausea—Capecitabine—breast cancer	8.81e-06	6.19e-05	CcSEcCtD
Lansoprazole—Urticaria—Methotrexate—breast cancer	8.77e-06	6.16e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Methotrexate—breast cancer	8.72e-06	6.13e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Methotrexate—breast cancer	8.72e-06	6.13e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.71e-06	6.12e-05	CcSEcCtD
Lansoprazole—Insomnia—Doxorubicin—breast cancer	8.64e-06	6.08e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Doxorubicin—breast cancer	8.58e-06	6.03e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Doxorubicin—breast cancer	8.52e-06	5.99e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Epirubicin—breast cancer	8.51e-06	5.98e-05	CcSEcCtD
Lansoprazole—Somnolence—Doxorubicin—breast cancer	8.5e-06	5.97e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Epirubicin—breast cancer	8.45e-06	5.94e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Doxorubicin—breast cancer	8.41e-06	5.91e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Doxorubicin—breast cancer	8.31e-06	5.84e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Doxorubicin—breast cancer	8.25e-06	5.8e-05	CcSEcCtD
Lansoprazole—Fatigue—Doxorubicin—breast cancer	8.24e-06	5.79e-05	CcSEcCtD
Lansoprazole—Urticaria—Epirubicin—breast cancer	8.2e-06	5.77e-05	CcSEcCtD
Lansoprazole—Constipation—Doxorubicin—breast cancer	8.17e-06	5.75e-05	CcSEcCtD
Lansoprazole—Pain—Doxorubicin—breast cancer	8.17e-06	5.75e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Epirubicin—breast cancer	8.16e-06	5.74e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Epirubicin—breast cancer	8.16e-06	5.74e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Methotrexate—breast cancer	8.13e-06	5.72e-05	CcSEcCtD
Lansoprazole—Asthenia—Methotrexate—breast cancer	7.92e-06	5.57e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Doxorubicin—breast cancer	7.87e-06	5.54e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Doxorubicin—breast cancer	7.81e-06	5.49e-05	CcSEcCtD
Lansoprazole—Pruritus—Methotrexate—breast cancer	7.81e-06	5.49e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Epirubicin—breast cancer	7.61e-06	5.35e-05	CcSEcCtD
Lansoprazole—Urticaria—Doxorubicin—breast cancer	7.59e-06	5.34e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Doxorubicin—breast cancer	7.55e-06	5.31e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Doxorubicin—breast cancer	7.55e-06	5.31e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Methotrexate—breast cancer	7.55e-06	5.31e-05	CcSEcCtD
Lansoprazole—Asthenia—Epirubicin—breast cancer	7.41e-06	5.21e-05	CcSEcCtD
Lansoprazole—Pruritus—Epirubicin—breast cancer	7.31e-06	5.14e-05	CcSEcCtD
Lansoprazole—Dizziness—Methotrexate—breast cancer	7.3e-06	5.13e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Epirubicin—breast cancer	7.07e-06	4.97e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Doxorubicin—breast cancer	7.04e-06	4.95e-05	CcSEcCtD
Lansoprazole—Vomiting—Methotrexate—breast cancer	7.02e-06	4.93e-05	CcSEcCtD
Lansoprazole—Rash—Methotrexate—breast cancer	6.96e-06	4.89e-05	CcSEcCtD
Lansoprazole—Dermatitis—Methotrexate—breast cancer	6.95e-06	4.89e-05	CcSEcCtD
Lansoprazole—Headache—Methotrexate—breast cancer	6.91e-06	4.86e-05	CcSEcCtD
Lansoprazole—Asthenia—Doxorubicin—breast cancer	6.86e-06	4.82e-05	CcSEcCtD
Lansoprazole—Dizziness—Epirubicin—breast cancer	6.83e-06	4.8e-05	CcSEcCtD
Lansoprazole—Pruritus—Doxorubicin—breast cancer	6.76e-06	4.75e-05	CcSEcCtD
Lansoprazole—Vomiting—Epirubicin—breast cancer	6.57e-06	4.62e-05	CcSEcCtD
Lansoprazole—Nausea—Methotrexate—breast cancer	6.56e-06	4.61e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Doxorubicin—breast cancer	6.54e-06	4.6e-05	CcSEcCtD
Lansoprazole—Rash—Epirubicin—breast cancer	6.51e-06	4.58e-05	CcSEcCtD
Lansoprazole—Dermatitis—Epirubicin—breast cancer	6.51e-06	4.57e-05	CcSEcCtD
Lansoprazole—Headache—Epirubicin—breast cancer	6.47e-06	4.55e-05	CcSEcCtD
Lansoprazole—Dizziness—Doxorubicin—breast cancer	6.32e-06	4.44e-05	CcSEcCtD
Lansoprazole—Nausea—Epirubicin—breast cancer	6.13e-06	4.31e-05	CcSEcCtD
Lansoprazole—Vomiting—Doxorubicin—breast cancer	6.08e-06	4.27e-05	CcSEcCtD
Lansoprazole—Rash—Doxorubicin—breast cancer	6.03e-06	4.24e-05	CcSEcCtD
Lansoprazole—Dermatitis—Doxorubicin—breast cancer	6.02e-06	4.23e-05	CcSEcCtD
Lansoprazole—Headache—Doxorubicin—breast cancer	5.99e-06	4.21e-05	CcSEcCtD
Lansoprazole—Nausea—Doxorubicin—breast cancer	5.68e-06	3.99e-05	CcSEcCtD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.48e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—breast cancer	1.48e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1B1—breast cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ERCC2—breast cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—STK11—breast cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP19A1—breast cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS1—breast cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO1—breast cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1B1—breast cancer	1.46e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMS—breast cancer	1.45e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CB—breast cancer	1.45e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.45e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.45e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2D6—breast cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—breast cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NCOR1—breast cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—breast cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—breast cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOA2—breast cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NCOA1—breast cancer	1.41e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—COMT—breast cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTP1—breast cancer	1.4e-06	1.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NCOA1—breast cancer	1.4e-06	1.61e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP19A1—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—STK11—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—breast cancer	1.38e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—breast cancer	1.38e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—STK11—breast cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP19A1—breast cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ITPR1—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FASN—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MED12—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—COMT—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—BCHE—breast cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTP1—breast cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A1—breast cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ERCC2—breast cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC5A5—breast cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDOA—breast cancer	1.35e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—breast cancer	1.34e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ITPR1—breast cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—breast cancer	1.32e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CB—breast cancer	1.32e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOA3—breast cancer	1.31e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—breast cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A1—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NQO1—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A2—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMS—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.29e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—COMT—breast cancer	1.29e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTP1—breast cancer	1.28e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.28e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—breast cancer	1.28e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NCOR1—breast cancer	1.28e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—COMT—breast cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—breast cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CPT1A—breast cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCG2—breast cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTR—breast cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTP1—breast cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP3A4—breast cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMS—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ITPR1—breast cancer	1.26e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—breast cancer	1.26e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ITPR1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PLA2G4A—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NCOR1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1B1—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPGDS—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBA1—breast cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—breast cancer	1.23e-06	1.42e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.22e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A1—breast cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—breast cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ACHE—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ERCC2—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—breast cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMS—breast cancer	1.19e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOA1—breast cancer	1.19e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A1—breast cancer	1.19e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMS—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NCOR1—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ERCC2—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—STK11—breast cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP19A1—breast cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NCOR1—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP17A1—breast cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO1—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS1—breast cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—breast cancer	1.13e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—breast cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A1—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2D6—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ERCC2—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A1—breast cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—breast cancer	1.11e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ERCC2—breast cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—COMT—breast cancer	1.09e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOA2—breast cancer	1.09e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTP1—breast cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—breast cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ITPR1—breast cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—breast cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FASN—breast cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BCHE—breast cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—breast cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC5A5—breast cancer	1.04e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—breast cancer	1.03e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—breast cancer	1.03e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CD—breast cancer	1.02e-06	1.18e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—breast cancer	1.02e-06	1.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMS—breast cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—breast cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A1—breast cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NQO1—breast cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—breast cancer	1e-06	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	1e-06	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOR1—breast cancer	1e-06	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.99e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—breast cancer	9.79e-07	1.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—breast cancer	9.67e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1B1—breast cancer	9.65e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—breast cancer	9.62e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—breast cancer	9.58e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—breast cancer	9.54e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—breast cancer	9.53e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1A1—breast cancer	9.48e-07	1.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.47e-07	1.09e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ERCC2—breast cancer	9.4e-07	1.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CD—breast cancer	9.38e-07	1.08e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—breast cancer	9.3e-07	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—breast cancer	9.26e-07	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOA1—breast cancer	9.21e-07	1.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.11e-07	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP19A1—breast cancer	9.08e-07	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STK11—breast cancer	9.08e-07	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CB—breast cancer	8.92e-07	1.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—breast cancer	8.86e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—breast cancer	8.84e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—breast cancer	8.84e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—breast cancer	8.83e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—breast cancer	8.76e-07	1.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—breast cancer	8.69e-07	1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—COMT—breast cancer	8.44e-07	9.72e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTP1—breast cancer	8.4e-07	9.67e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CD—breast cancer	8.38e-07	9.65e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—breast cancer	8.28e-07	9.54e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—breast cancer	8.27e-07	9.52e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ITPR1—breast cancer	8.26e-07	9.52e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CB—breast cancer	8.18e-07	9.42e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CD—breast cancer	8.18e-07	9.42e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—breast cancer	8.15e-07	9.39e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—breast cancer	8.11e-07	9.33e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—breast cancer	8.07e-07	9.29e-06	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—breast cancer	8.04e-07	9.25e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—breast cancer	7.95e-07	9.15e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—breast cancer	7.91e-07	9.11e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMS—breast cancer	7.81e-07	8.99e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.79e-07	8.97e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—breast cancer	7.72e-07	8.89e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.72e-07	8.89e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOR1—breast cancer	7.72e-07	8.89e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—breast cancer	7.72e-07	8.89e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—breast cancer	7.71e-07	8.88e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CD—breast cancer	7.7e-07	8.87e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CD—breast cancer	7.64e-07	8.8e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—breast cancer	7.61e-07	8.76e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—breast cancer	7.54e-07	8.68e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—breast cancer	7.42e-07	8.55e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—breast cancer	7.39e-07	8.51e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A1—breast cancer	7.32e-07	8.42e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CB—breast cancer	7.3e-07	8.41e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—breast cancer	7.28e-07	8.38e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ERCC2—breast cancer	7.26e-07	8.36e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—breast cancer	7.23e-07	8.33e-06	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—breast cancer	7.22e-07	8.31e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—breast cancer	7.21e-07	8.31e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CB—breast cancer	7.13e-07	8.21e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—breast cancer	7.07e-07	8.14e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—breast cancer	7.06e-07	8.13e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—breast cancer	6.82e-07	7.85e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CB—breast cancer	6.72e-07	7.73e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CB—breast cancer	6.66e-07	7.67e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—breast cancer	6.65e-07	7.66e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—breast cancer	6.6e-07	7.6e-06	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—breast cancer	6.56e-07	7.56e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CD—breast cancer	6.53e-07	7.52e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—breast cancer	6.44e-07	7.42e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—breast cancer	6.31e-07	7.27e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—breast cancer	6.29e-07	7.24e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—breast cancer	6.16e-07	7.1e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—breast cancer	6.16e-07	7.09e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—breast cancer	5.8e-07	6.68e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—breast cancer	5.75e-07	6.63e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—breast cancer	5.73e-07	6.6e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CB—breast cancer	5.69e-07	6.55e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—breast cancer	5.64e-07	6.49e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—breast cancer	5.44e-07	6.26e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CD—breast cancer	5.04e-07	5.8e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—breast cancer	4.99e-07	5.74e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—breast cancer	4.97e-07	5.73e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—breast cancer	4.92e-07	5.66e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—breast cancer	4.76e-07	5.48e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—breast cancer	4.45e-07	5.13e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—breast cancer	4.44e-07	5.12e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CB—breast cancer	4.39e-07	5.06e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—breast cancer	4.35e-07	5.01e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—breast cancer	4.34e-07	5e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—breast cancer	4.09e-07	4.71e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—breast cancer	4.07e-07	4.69e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—breast cancer	4.06e-07	4.67e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—breast cancer	3.79e-07	4.37e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—breast cancer	3.64e-07	4.19e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—breast cancer	3.55e-07	4.09e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—breast cancer	3.47e-07	3.99e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—breast cancer	3.34e-07	3.85e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—breast cancer	3.32e-07	3.82e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—breast cancer	2.83e-07	3.26e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—breast cancer	2.68e-07	3.08e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—breast cancer	2.19e-07	2.52e-06	CbGpPWpGaD
